AfDB commits $746M to Egypt in 2025, targeting private sector, pharma, and clean energy

The African Development Bank (AfDB) will provide Egypt with $746 million in funding in 2025, matching the amount projected for 2026, according to Abdourahmane Diaw, AfDB’s Country Manager in Egypt.

This support encompasses both sovereign and non-sovereign operations, reinforcing Egypt’s standing as the Bank’s second-largest regional member country shareholder—after Nigeria—and the third-largest overall.

Speaking to Daily News Egypt, Diaw revealed that AfDB’s current portfolio in Egypt totals $2.045 billion, with private sector operations accounting for $800 million, or 39%. The Bank is currently involved in 13 active private sector projects: seven in the power sector, three in finance, and one each in healthcare, industry, and agribusiness.

AfDB is advancing four major initiatives in Egypt for 2025: Minapharm Expansion and Renovation Program

Approved in March 2025, this project aims to scale up Egypt’s pharmaceutical capacity by producing biosimilar monoclonal antibodies for oncology and autoimmune diseases—addressing a critical gap in Africa’s healthcare landscape.